J J Treanor
Affiliation: University of Rochester
- Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjectsJ J Treanor
University of Rochester, Infectious Diseases Unit, NY 14642, USA
Vaccine 16:1756-60. 1998..Further studies of multivalent cold-adapted influenza vaccines used in combination with inactivated vaccine should be performed...
- Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B virusesJ J Treanor
Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
Vaccine 18:899-906. 1999..These results are consistent with those of previous studies using monovalent preparations of cold-adapted influenza vaccine in this model, and indicate that CAIV-T will be an effective means to prevent influenza illness in adults...
- Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humansJ J Treanor
Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
Vaccine 19:1732-7. 2001..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
- Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study GroupJ J Treanor
Infectious Diseases Unit, University of Rochester, NY 14642, USA
JAMA 283:1016-24. 2000..Previous studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza...